WHO issued an alert on Wednesday over a cold and cough syrup manufactured in India. The WHO added it might be linked to the death of 66 children in Gambia.
HIGHLIGHTS
- WHO launched probe after 66 children died
- Indian made cold and cough syrups are in question.
- A link between the syrups and acute kidney diseases have been cited.
The cold and cough syrups were manufactured by Maiden Pharmaceuticals in India. In addition to this WHO has also launched a probe in the case regarding the death of 66 children in Gambia.
“Laboratory analysis of samples of each of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants. To date, these four products have been identified in Gambia, but may have been distributed, through informal markets, to other countries or regions,” the WHO said in the alert. ( reported Indian Express)
The cold and cough syrups have been linked to the acute kidney injuries and death of 66 children. The four syrups: Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup are manufactured by Haryana-based Indian pharmaceutical company.
“If you have these substandard products, please do not use them. If you, or someone you know, have used these products or suffered any adverse reaction/event after use, you are advised to seek immediate medical advice from a qualified healthcare professional and report the incident to the National Regulatory Authority or National Pharmacovigilance Centre,” the WHO alert said. (reported Indian Express). Following this India has launched an urgent investigation after WHO issued the alert.
(With inputs from various media outlets)
